Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

Innate Killer Summit 2019

19 March 2019 08:00 - 21 March 2019 17:00, San Diego, United States


Introduction
The Innate Killer Summit 2019 discusses safer, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy.

It will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability.

Bringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.
Speakers
  • Sonny Hsiao CEO, President and Co-Founder Acepodia Inc. United States
  • Martin Treder, CSO, Affimed United States
  • Robin Parihar, Assistant Professor of Pediatric Hematology- Oncology, Baylor College of Medicine United States
  • Xiaokui Zhang, CSO, Celularity United States
  • Robert Hariri, Chairman & CEO, Celularity United States
  • Noah Merin, Assistant Professor, Cedars-Sinai Medical Center United States
  • Robert Igarashi, CSO, Cyto-Sen Therapeutics United States
  • Emily Mace, Assistant Professor of Pediatrics, Columbia University United States
  • Rizwan Romee, Director of Haploidentical Donor Transplant Program, Dana-Farber Cancer Institute United States
  • Bob Valamehr, CDO, Fate Therapeutics United States
  • Amir Horowitz, Assistant Professor of Oncological Sciences, Ichan School of Medicine United States
  • Mark Lowdell, CSO, ImmuneBio Inc United States
  • Lawrence Lamb, Chair of the Scientific Advisory Board, Incysus Therapeutics Inc. United States
  • Evren Alici, Assistant Professor of Hematology, Karolinska Institutet United States
  • Lotte Wieten, Department Head of Transplantation Immunology, Maastricht University United States
  • Patrick Soon-Shiong, Founder & CEO, NantWorks United States
  • James Trager, Senior Vice President of Research and Development, Nkarta Therapeutics United States
  • Stacey Cranert, Research Scientist, Poseida Therapeutics United States
  • Alicja Copik, Research Assistant Professor, Burnett School of Biomedical Sciences United States
  • Anahid Jewett ,Professor, UCLA School of Dentistry and Medicine United States

Venue
Hilton San Diego Gaslamp Quarter

Hilton San Diego Gaslamp Quarter, 401 K Street, San Diego, 92101, United States

Organised by
Hanson Wade
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*